Avita Medical Inc (RCEL) Stock Price, Quote & News

Company Profile

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to...

Industry: Medical Devices

Sector: Healthcare

Phone: 661 367 9170

Fax: 661 367 9180

Website: avitamedical.com

Address:

28159 Avenue Stanford, Suite 220, Valencia, United States

okeydokey_artichokey May. 13 at 6:53 PM

$RCEL Still early days, but it would be nice to see a small rev bump from Cohealyx. A great ecosystem, but I think near-term earnings gonna be choppy . glta

0 · Reply

BeefStewart May. 13 at 4:56 PM

$RCEL One day more.... one more day!

0 · Reply

All_City_Baby May. 13 at 2:39 PM

$RCEL

0 · Reply

scottgrant2 May. 12 at 9:06 PM

$RCEL earnings predictions?

1 · Reply

scottgrant2 May. 12 at 7:20 PM

$RCEL accumulating going on by some big fish..

1 · Reply

BeefStewart May. 11 at 5:39 PM

$RCEL what needs to happen for this to get to $20+ ?

1 · Reply

scottgrant2 May. 11 at 4:12 PM

$RCEL cup with handle forming

0 · Reply

BeefStewart May. 11 at 1:44 PM

$RCEL I suppose the other thing here is "squeeze potential." I don't rely on short squeezes. I do see how a low float stock that is heavily shorted could be a candidate for a short squeeze, though...

0 · Reply

BeefStewart May. 11 at 1:39 PM

$RCEL I haven't really followed the opening moves here before today. Is a 35ish thousand share trade a strong opening volume? I would guess so, given the avg daily volume is just over 220k....

0 · Reply

scottgrant2 May. 11 at 2:29 AM

$MNKD $RCEL $SCPH

0 · Reply

Avita Medical appoints Cary Vance as CEO

Apr 30, 2026, 8:50 AM EDT - 13 days ago

AVITA Medical Names Cary Vance as Chief Executive Officer

2026-04-29T21:09:12.000Z - 13 days ago

Avita Medical receives regulatory clearance for Recell Go

Apr 29, 2026, 4:05 PM EDT - 13 days ago

AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO

Apr 23, 2026, 4:10 PM EDT - 19 days ago

AVITA Medical to Announce First Quarter 2026 Financial Results

Apr 16, 2026, 4:30 PM EDT - 26 days ago

AVITA Medical Transcript: KOL event

Apr 15, 2026, 9:20 AM EDT - 4 weeks ago

AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association

2026-04-14T11:59:03.000Z - 4 weeks ago

Avita Medical announces interim results from Cohealyx-I multi-center study

Apr 14, 2026, 7:45 AM EDT - 4 weeks ago

AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting

Apr 13, 2026, 9:00 AM EDT - 4 weeks ago

AVITA Medical, Inc. Investigated by the Portnoy Law Firm

2026-04-08T20:21:41.000Z - 4 weeks ago

Avita Medical secures 10-year BARDA agreement worth $25.5M

Apr 7, 2026, 4:10 PM EDT - 5 weeks ago

AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data

2026-03-26T14:20:13.000Z - 6 weeks ago

Avita Medical stock pullback creates buying opportunity, says Northland

2026-03-05T14:13:45.000Z - 2 months ago

Avita Medical initiated with an Outperform at Northland

2026-03-05T12:51:41.000Z - 2 months ago

Avita Medical initiated with an Outperform at Northland

Mar 4, 2026, 11:10 AM EST - 2 months ago

AVITA Medical Transcript: TD Cowen 46th Annual Health Care Conference

Feb 23, 2026, 4:15 PM EST - 2 months ago

AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference

Feb 18, 2026, 5:00 PM EST - 2 months ago

AVITA Medical Transcript: Status update

2026-02-12T21:55:45.000Z - 3 months ago

Avita Medical reports Q4 EPS (38c), consensus (55c)

2026-02-12T21:55:18.000Z - 3 months ago

Avita Medical sees FY26 revenue $80M-$85M, consensus $123.5M

Feb 12, 2026, 4:30 PM EST - 3 months ago

AVITA Medical Earnings Call Transcript: Q4 2025

Feb 12, 2026, 4:01 PM EST - 3 months ago

AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results

2026-01-26T02:10:06.000Z - 3 months ago

Avita Medical announces data from Boswick Burn & Wound symposium

2026-01-16T13:41:04.000Z - 4 months ago

Avita Medical price target raised to $3.50 from $3 at Lake Street

Jan 14, 2026, 8:15 PM EST - 4 months ago

AVITA Medical Transcript: 44th Annual J.P. Morgan Healthcare Conference

2026-01-13T13:36:59.000Z - 4 months ago

Avita Medical sees Q4 revenue $17.6M vs. $18.4M last year

2026-01-13T13:36:35.000Z - 4 months ago

Avita Medical sees FY26 revenue $80M-$85M vs. $71.6M in FY24

2026-01-13T13:35:24.000Z - 4 months ago

Avita Medical closes five-year credit facility up to $60M

Jan 13, 2026, 8:25 AM EST - 4 months ago

AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook

Jan 5, 2026, 4:05 PM EST - 4 months ago

AVITA Medical Announces Changes to its Board of Directors

Dec 18, 2025, 4:15 PM EST - 5 months ago

AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 4, 2025, 8:30 AM EST - 5 months ago

AVITA Medical Transcript: Piper Sandler 37th Annual Healthcare Conference

Nov 24, 2025, 4:15 PM EST - 6 months ago

AVITA Medical to Present at the Piper Sandler 37ᵗʰ Annual Healthcare Conference

2025-11-20T11:25:41.000Z - 6 months ago

Avita Medical upgraded to Neutral from Sell at BTIG

Nov 12, 2025, 5:00 PM EST - 6 months ago

AVITA Medical Transcript: Status Update

2025-11-07T13:51:50.000Z - 6 months ago

Avita Medical price target lowered to $3 from $4 at Lake Street

2025-11-06T23:20:28.000Z - 6 months ago

Avita Medical reports Q3 EPS (46c), consensus (45c)

Nov 6, 2025, 4:30 PM EST - 6 months ago

AVITA Medical Earnings Call Transcript: Q3 2025

2025-11-03T13:40:44.000Z - 6 months ago

Avita Medical announces two presentations at SRBC on RECELL System

Nov 3, 2025, 8:30 AM EST - 6 months ago

Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment

Oct 29, 2025, 4:15 PM EDT - 6 months ago

AVITA Medical to Announce Third Quarter 2025 Financial Results

2025-10-28T20:45:34.000Z - 7 months ago

Avita Medical announces Australia Medical Services Advisory Committee support

Oct 28, 2025, 4:30 PM EDT - 7 months ago

AVITA Medical Welcomes Support for RECELL® in Burns in Australia

2025-10-20T12:47:28.000Z - 7 months ago

Avita Medical price target lowered to $5.50 from $8 at TD Cowen

Oct 16, 2025, 6:15 PM EDT - 7 months ago

AVITA Medical Announces CEO Transition

Oct 1, 2025, 8:30 AM EDT - 8 months ago

CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds

Sep 9, 2025, 3:47 PM EDT - 8 months ago

AVITA Medical, Inc. Investors: Company Investigated by the Portnoy Law Firm

Sep 8, 2025, 4:05 PM EDT - 8 months ago

AVITA Medical Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 21, 2025, 4:05 PM EDT - 9 months ago

AVITA Medical Announces September Investor Conference Participation

Aug 12, 2025, 8:30 AM EDT - 9 months ago

AVITA Medical Successfully Completes Australian Equity Raise

Aug 10, 2025, 7:00 PM EDT - 9 months ago

AVITA Medical to Host Investor Webinar Briefing

Aug 7, 2025, 4:30 PM EDT - 9 months ago

AVITA Medical Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:05 PM EDT - 9 months ago

AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation

Jul 28, 2025, 4:05 PM EDT - 10 months ago

AVITA Medical to Announce Second Quarter 2025 Financial Results

Jun 3, 2025, 8:00 PM EDT - 1 year ago

AVITA Medical's RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards

May 13, 2025, 2:00 PM EDT - 1 year ago

AVITA Medical Transcript: Status Update

May 8, 2025, 4:30 PM EDT - 1 year ago

AVITA Medical Earnings Call Transcript: Q1 2025

May 8, 2025, 4:03 PM EDT - 1 year ago

AVITA Medical Reports First Quarter 2025 Financial Results

Apr 17, 2025, 4:05 PM EDT - 1 year ago

AVITA Medical to Announce First Quarter 2025 Financial Results

Apr 9, 2025, 4:05 PM EDT - 1 year ago

AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025

Apr 3, 2025, 4:03 PM EDT - 1 year ago

AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity

Mar 17, 2025, 4:05 PM EDT - 1 year ago

AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific

Mar 4, 2025, 11:50 AM EST - 1 year ago

AVITA Medical Transcript: TD Cowen 45th Annual Healthcare Conference

Feb 26, 2025, 5:30 PM EST - 1 year ago

AVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care Conference

Feb 18, 2025, 5:00 PM EST - 1 year ago

AVITA Medical Transcript: Investor Update

Feb 13, 2025, 4:30 PM EST - 1 year ago

AVITA Medical Earnings Call Transcript: Q4 2024

Feb 13, 2025, 4:01 PM EST - 1 year ago

AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Jan 16, 2025, 12:00 PM EST - 1 year ago

AVITA Medical Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 7, 2025, 10:12 PM EST - 1 year ago

AVITA Medical's shares sink 19% after another forecast cut

Jan 7, 2025, 4:35 PM EST - 1 year ago

AVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance

Dec 23, 2024, 4:02 PM EST - 1 year ago

AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds

Dec 19, 2024, 5:05 PM EST - 1 year ago

AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market

Dec 18, 2024, 4:08 PM EST - 1 year ago

AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 3, 2024, 11:30 AM EST - 1 year ago

AVITA Medical Transcript: Piper Sandler 36th Annual Healthcare Conference

Nov 25, 2024, 4:02 PM EST - 1 year ago

AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference

Nov 12, 2024, 5:00 PM EST - 1 year ago

AVITA Medical Transcript: Status Update

Nov 12, 2024, 4:03 PM EST - 1 year ago

AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand

okeydokey_artichokey May. 13 at 6:53 PM

$RCEL Still early days, but it would be nice to see a small rev bump from Cohealyx. A great ecosystem, but I think near-term earnings gonna be choppy . glta

0 · Reply

BeefStewart May. 13 at 4:56 PM

$RCEL One day more.... one more day!

0 · Reply

All_City_Baby May. 13 at 2:39 PM

$RCEL

0 · Reply

scottgrant2 May. 12 at 9:06 PM

$RCEL earnings predictions?

1 · Reply

scottgrant2 May. 12 at 7:20 PM

$RCEL accumulating going on by some big fish..

1 · Reply

BeefStewart May. 11 at 5:39 PM

$RCEL what needs to happen for this to get to $20+ ?

1 · Reply

scottgrant2 May. 11 at 4:12 PM

$RCEL cup with handle forming

0 · Reply

BeefStewart May. 11 at 1:44 PM

$RCEL I suppose the other thing here is "squeeze potential." I don't rely on short squeezes. I do see how a low float stock that is heavily shorted could be a candidate for a short squeeze, though...

0 · Reply

BeefStewart May. 11 at 1:39 PM

$RCEL I haven't really followed the opening moves here before today. Is a 35ish thousand share trade a strong opening volume? I would guess so, given the avg daily volume is just over 220k....

0 · Reply

scottgrant2 May. 11 at 2:29 AM

$MNKD $RCEL $SCPH

0 · Reply

BeefStewart May. 10 at 11:54 PM

$RCEL @scottgrant2 Absolutely about disciplined spending and deeper penetration into existing burn centers, as well as expanding the range of products (in the medium term) that will be available so that Avita can offer more comprehensive treatments for wound care. I believe the company has moved past it's lowest point, and I wouldn't be completely shocked if it gets acquired at a potentially frustrating valuation (for longer-term shareholders), similar to how $MNKD acquired $SCPH

0 · Reply

BeefStewart May. 9 at 6:31 PM

$RCEL wondering if this will go the route of $SCPH @OldManLogan any thoughts here?

1 · Reply

BeefStewart May. 8 at 5:31 PM

$RCEL I believe this is an $8+ stock in disguise.

1 · Reply

BeefStewart May. 8 at 3:58 PM

$RCEL Just an arbitrary ~10% drop in a week. Nothing to see here

0 · Reply

BeefStewart May. 8 at 3:47 PM

$RCEL @MITornado seems to be somewhat heavily shorted. The prevailing belief is that they won't turn the biz around. Perceptive Advisors stepped in to replace Orbimed. Perceptive previously helped $ADMA I believe Q1 numbers will be promising.

1 · Reply

MITornado May. 8 at 3:28 PM

$RCEL rejoined the party. Small potatoes really, but I like what I see. What am I missing? Why is this price so depressed?

0 · Reply

BeefStewart May. 8 at 3:00 PM

$RCEL I feel this is quite significant

1 · Reply

BeefStewart May. 8 at 2:51 PM

$RCEL

0 · Reply

BeefStewart May. 8 at 12:41 AM

$RCEL Anyone have any updated thoughts here?

1 · Reply

BeefStewart May. 7 at 11:11 PM

$RCEL 👽🥰

1 · Reply

BeefStewart May. 7 at 6:03 PM

$RCEL @DJarrett @GoldmanSlaps @techjerk I loaded up today Hoping for the best... .4.23 avg.

2 · Reply

BeefStewart May. 7 at 5:37 PM

$RCEL Anyone holding through earnings?

2 · Reply

Market Cap	134.50M
Revenue (ttm)	71.61M
Net Income (ttm)	-48.59M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-67.85%
Debt to Equity Ratio	-2.58

Volume	98,210
Avg Vol	210,530
Day's Range	N/A - N/A
Shares Out	30.78M
Stochastic %K	59%
Beta	1.90
Analysts	Sell
Price Target	$7.25